Baillie Gifford - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$4,272
-18.2%
1860.0%0.00%
Q4 2022$5,223
+4.5%
1860.0%0.00%
Q3 2022$5,000
+25.0%
1860.0%0.00%
Q2 2022$4,000
-20.0%
1860.0%0.00%
Q1 2022$5,000
-16.7%
1860.0%0.00%
Q4 2021$6,000
-33.3%
1860.0%0.00%
Q3 2021$9,000
-10.0%
1860.0%0.00%
Q2 2021$10,0000.0%1860.0%0.00%
Q1 2021$10,000
+25.0%
186
+1.6%
0.00%
Q4 2020$8,000
-90.2%
183
-89.3%
0.00%
Q4 2019$82,000
-99.8%
1,709
-99.8%
0.00%
-100.0%
Q3 2019$35,113,000
-34.8%
1,083,694
+0.4%
0.04%
-29.8%
Q2 2019$53,862,000
-8.4%
1,079,829
+23.8%
0.06%
-10.9%
Q1 2019$58,822,000
+47.9%
872,225
+1.1%
0.06%
+23.1%
Q4 2018$39,779,000
-23.1%
862,715
+28.7%
0.05%
-7.1%
Q3 2018$51,705,000
-2.0%
670,443
+7.0%
0.06%
-1.8%
Q2 2018$52,779,000
+10.9%
626,603
+7.6%
0.06%
+1.8%
Q1 2018$47,607,000582,1410.06%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 2,710,061$67,074,0101.80%
Bellevue Group AG 4,013,500$99,334,1251.60%
Eagle Health Investments LP 267,630$6,623,8431.46%
ARMISTICE CAPITAL, LLC 3,324,000$82,269,0001.26%
SUVRETTA CAPITAL MANAGEMENT, LLC 454,000$11,236,5000.61%
Frazier Life Sciences Management, L.P. 292,002$7,227,0500.48%
ArrowMark Colorado Holdings LLC 1,573,359$38,940,6350.47%
Deep Track Capital, LP 422,247$10,450,6130.40%
FARALLON CAPITAL MANAGEMENT LLC 2,750,829$68,083,0180.34%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 24,000$593,5200.20%
View complete list of AGIOS PHARMACEUTICALS INC shareholders